Supplementary Material for: LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway
Yuzhang Wu(Army Medical University), Ning Zhou(Tongji Hospital), Qiang Xie(University of Science and Technology of China), Can J., Hao S.
Cited by 0
Related Papers
The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes
|medRxiv|2020|387
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism
|Nature Communications|2017|185
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
|Science China Life Sciences|2020|176
Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
|Science China Life Sciences|2020|159